Treatment of Cardiovascular Disease With Low Dose Rivaroxaban in Advanced Chronic Kidney Disease

NCT03969953 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1753

Enrollment

OTHER

Sponsor class

Conditions

Chronic Kidney Diseases
Dialysis-dependent Kidney Failure
Cardiovascular Disease

Interventions

DRUG: Rivaroxaban 2.5 Mg Oral Tablet
OTHER: Placebo

Sponsor

The George Institute

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]